These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12401507)

  • 21. Cabergoline treatment of pregnant women with macroprolactinomas.
    Laloi-Michelin M; Ciraru-Vigneron N; Meas T
    Int J Gynaecol Obstet; 2007 Oct; 99(1):61-2. PubMed ID: 17602689
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine.
    Delgrange E; Maiter D; Donckier J
    Eur J Endocrinol; 1996 Apr; 134(4):454-6. PubMed ID: 8640297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cabergoline for hyperprolactinemia.
    Med Lett Drugs Ther; 1997 Jun; 39(1003):58-9. PubMed ID: 9205431
    [No Abstract]   [Full Text] [Related]  

  • 24. Surveillance of bromocriptine in pregnancy.
    Turkalj I; Braun P; Krupp P
    JAMA; 1982 Mar; 247(11):1589-91. PubMed ID: 7062462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis.
    Youssef MA; van Wely M; Hassan MA; Al-Inany HG; Mochtar M; Khattab S; van der Veen F
    Hum Reprod Update; 2010; 16(5):459-66. PubMed ID: 20354100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study.
    Glueck CJ; Phillips H; Cameron D; Sieve-Smith L; Wang P
    Fertil Steril; 2001 Jan; 75(1):46-52. PubMed ID: 11163815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exposure to golimumab during pregnancy: Results from the Company's global safety database.
    Otero-Lobato M; Adeyemo A; Higley M; Lomax KG; Geldhof A; Esslinger S
    Pharmacol Res Perspect; 2024 Aug; 12(4):e1240. PubMed ID: 38970433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiepileptic drugs, foetal malformations and spontaneous abortions.
    Vajda FJ; O'Brien TJ; Graham JE; Hitchcock AA; Lander CM; Eadie MJ
    Acta Neurol Scand; 2017 Mar; 135(3):360-365. PubMed ID: 27573510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of cabergoline to treat primary and secondary anestrus in dogs.
    Gobello C; Castex G; Corrada Y
    J Am Vet Med Assoc; 2002 Jun; 220(11):1653-4. PubMed ID: 12051504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas.
    Sant' Anna BG; Musolino NRC; Gadelha MR; Marques C; Castro M; Elias PCL; Vilar L; Lyra R; Martins MRA; Quidute ARP; Abucham J; Nazato D; Garmes HM; Fontana MLC; Boguszewski CL; Bueno CB; Czepielewski MA; Portes ES; Nunes-Nogueira VS; Ribeiro-Oliveira A; Francisco RPV; Bronstein MD; Glezer A
    Pituitary; 2020 Apr; 23(2):120-128. PubMed ID: 31728906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan.
    Nakajima K; Watanabe O; Mochizuki M; Nakasone A; Ishizuka N; Murashima A
    Mod Rheumatol; 2016 Sep; 26(5):667-71. PubMed ID: 26873562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy outcomes in women reporting ingestion of levosulpiride in early pregnancy.
    Shin YJ; Choi JS; Ahn HK; Ryu HM; Kim MY; Han JY
    J Obstet Gynaecol; 2017 Nov; 37(8):992-995. PubMed ID: 28631490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.
    Chun-Fai-Chan B; Koren G; Fayez I; Kalra S; Voyer-Lavigne S; Boshier A; Shakir S; Einarson A
    Am J Obstet Gynecol; 2005 Mar; 192(3):932-6. PubMed ID: 15746694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy outcome in Norway after Chernobyl.
    Irgens LM; Lie RT; Ulstein M; Skeie Jensen T; Skjaerven R; Sivertsen F; Reitan JB; Strand F; Strand T; Egil Skjeldestad F
    Biomed Pharmacother; 1991; 45(6):233-41. PubMed ID: 1912379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
    Kanda K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of serious complications from induced abortion: do personal characteristics make a difference?
    Buehler JW; Schulz KF; Grimes DA; Hogue CJ
    Am J Obstet Gynecol; 1985 Sep; 153(1):14-20. PubMed ID: 4036997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abortion surveillance - United States, 2010.
    Pazol K; Creanga AA; Burley KD; Hayes B; Jamieson DJ;
    MMWR Surveill Summ; 2013 Nov; 62(8):1-44. PubMed ID: 24280963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of spontaneous abortions--the effect of previous abortions.
    Anokute CC
    J R Soc Health; 1987 Feb; 107(1):31-3. PubMed ID: 3102738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes.
    Bérard A; Zhao JP; Shui I; Colilla S
    Ann Rheum Dis; 2018 Apr; 77(4):500-509. PubMed ID: 29222350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study.
    Carizza C; Abdelmassih V; Abdelmassih S; Ravizzini P; Salgueiro L; Salgueiro PT; Jine LT; Nagy P; Abdelmassih R
    Reprod Biomed Online; 2008 Dec; 17(6):751-5. PubMed ID: 19079957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.